Heart Failure - NYHA II - IV: Clinical Trials

17 trials for Heart Failure - NYHA II - IV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 recruiting, 5 not yet recruiting, 2 completed, 1 active not recruiting. 6 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable6Recruiting 4, Completed 1, Not yet recruiting 1
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1
Phase 41Recruiting 1

Follow Heart Failure - NYHA II - IV: new trials by email Literature Review of Heart Failure - NYHA II - IV trials Research Report on Heart Failure - NYHA II - IV

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mitral Valve Edge-to-Edge Repair in Patients With Exercise-Induced Severe Mitral Regurgitation
Guideline-Directed Medical Therapy (GDMT), Mitral valve TEER - Heart Failure - NYHA II - IV, Mitral Regurgitation Functional
Not applicableRecruitingJena University Hospital2462026-09-162026-10-05
Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways
COR Wearable ECG Monitoring, Cor360 Clinician-Facing Decision-Aid Reporting - Cardiovascular Diseases, Cardiovascular Diseases Risk
Enrolling by invitationPeerbridge Health, Inc10002026-08-202026-08-21
AI-Optimized Single-Feature Recognition Model for Heart Failure
Cardiac Sound, Heart Failure - NYHA II - IV
RecruitingVivalink502026-07-162026-07-21
REstoration of SYNChronous Cardiac Function Due to Physiologic cArdiac Pacing Modalities With Clinical Endpoints
Physiologic cardiac resynchronization using conduction system pacing and selective LV lead optimization. - Heart Failure - NYHA II - IV, Left Bundle Branch Area Pacing
Not yet recruitingUniversity of Pecs502026-06-292026-07-10
Ted Rogers Understanding of Exacerbations in Heart Failure 2: Monitor
Heart Failure, Heart Failure - NYHA II - IV
RecruitingUniversity Health Network, Toronto3602026-06-162026-07-06
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
FibroScan, Right-sided Heart Catheterization, Transthoracic echocardiography - Heart Failure, Heart Failure - NYHA II - IV
Not applicableRecruitingEchosens1492026-04-232026-09-23
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
Furosemide intravenous solution - Heart Failure, Heart Failure - NYHA II - IV
Phase 4RecruitingLakeland Regional Health Systems, Inc.6002026-04-012026-04-09
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
CRT-D with a Quadripolar LV lead, CRT-D with INGEVITY+ pace/sense lead - Heart Failure - NYHA II - IV
Not applicableRecruitingBoston Scientific Corporation8502025-10-222026-10-05
Cardiovascular Performance and Exercise Response in Patients With Persistent or Permanent Atrial Fibrillation and Heart Failure Pre and Post Cardioversion or Pace and Ablate
Atrial Fibrillation (AF), Heart Failure - NYHA II - IV
Not yet recruitingHabib Khan402025-10-012025-10-03
Effects of a 20-Minute Mindfulness-Based Breathing Exercise on Dyspnea, Fatigue, and Sleep Quality in Patients With Heart Failure
20-minute mindfulness-based breathing exercise, Control (Standard treatment) - Heart Failure, Heart Failure - NYHA II - IV
Not applicableNot yet recruitingFirat University722025-08-152025-07-01
Low Dose Radiotherapy for Heart Failure
Radiation Therapy - Heart Failure - NYHA II - IV
Phase 1 / Phase 2Not yet recruitingHospital do Coracao102025-07-142025-06-25
Remote Monitoring of Cardiac Mechanics in Heart Failure Patients
Continuous monitroing - Heart Failure, Heart Failure - NYHA II - IV
RecruitingAalborg University2002025-06-112026-01-16
Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study
Heart Failure network care - Heart Failure - NYHA II - IV
Not applicableRecruitingUniversity of Leipzig10002024-11-282026-05-06
Calibration of AlgoRithm for Detection of Cardiac Decompensation Via Parametric Objects (CARDCOP)
Heart Failure - NYHA II - IV
Not yet recruitingUniversity Hospital, Brest6402024-11-012024-10-28
An Optimization Pilot to Optimize An Early Palliative Care Intervention for Advanced Heart Failure
UPHOLDS (Utilizing Palliative Care for Heart Failure Optimized using Lay Navigators to Decrease Suffering) - Chronic Illness, Heart Failure - NYHA II - IV
Not applicableCompletedUniversity of Alabama at Birmingham322024-08-152026-09-22
Effect of Genetic Polymorphism on the Clinical Outcome to SGLT2 Inhibitors in Heart Failure Patients
SGLT2 inhibitor (Dapagliflozin 10mg) - Heart Failure - NYHA II - IV, Cardiac Fibrosis
Active not recruitingAin Shams University2002023-11-222025-03-30
Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy
Randomization of Pre-knowledge of CT coronary venography - Heart Failure - NYHA II - IV, Wide QRS Complex
CompletedMassachusetts General Hospital382009-02-012022-10-03

Narrower conditions

Heart Failure (8)  ·  Arrhythmias, Cardiac (1)  ·  Atrial Fibrillation (1)  ·  Bundle-Branch Block (1)  ·  Cardiac Conduction System Disease (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Death, Sudden, Cardiac (1)  ·  Edema (1)  ·  Epilepsy (1)  ·  Fatigue (1)  ·  Heart Arrest (1)  ·  Myocardial Ischemia (1)  ·  Primary Dysautonomias (1)  ·  Sleep Apnea, Obstructive (1)

Broader conditions

Heart Diseases (10)  ·  Cardiovascular Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (4)  ·  Arrhythmias, Cardiac (2)  ·  Dyssomnias (2)  ·  Nervous System Diseases (2)  ·  Signs and Symptoms (2)  ·  Sleep Disorders, Intrinsic (2)  ·  Sleep Wake Disorders (2)  ·  Apnea (1)  ·  Autonomic Nervous System Diseases (1)  ·  Brain Diseases (1)  ·  Cardiac Conduction System Disease (1)  ·  Central Nervous System Diseases (1)

Interventions

Furosemide (1)  ·  Radiotherapy (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  dapagliflozin (1)

Sponsors

Aalborg University (1)  ·  Ain Shams University (1)  ·  Boston Scientific Corporation (1)  ·  Echosens (1)  ·  Firat University (1)  ·  Habib Khan (1)  ·  Hospital do Coracao (1)  ·  Jena University Hospital (1)  ·  Lakeland Regional Health Systems, Inc. (1)  ·  Massachusetts General Hospital (1)  ·  Peerbridge Health, Inc (1)  ·  University Health Network, Toronto (1)  ·  University Hospital, Brest (1)  ·  University of Alabama at Birmingham (1)  ·  University of Leipzig (1)

Countries

United States (6)  ·  Germany (3)  ·  France (2)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Hungary (1)  ·  Poland (1)

Top investigators

Anas Bizanti, MD (1)  ·  Andrew Lurie, DO (1)  ·  Bassem Zarif, MD (1)  ·  Chris McIntosh, PhD (1)  ·  Christian Schulze, Prof. Dr. (1)  ·  Heather Ross, MD (1)  ·  Jagmeet P Singh, MD, PhD (1)  ·  Maximilian Spieker, PD Dr. (1)  ·  Sandeep Gulati, PhD (1)  ·  Yasbanoo Moayedi, MD (1)

Results publications

PMID 29572087, PMID 31865389

NIH funding

K23HL098370 (1), R00NR019854 (1)